Cargando…

The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression

Castration-resistant prostate cancer (CRPC) remains prostate cancer research and treatment bottleneck. Abnormal androgen receptor (AR) activation still has a pivotal role in CRPC. Multiple mechanisms involve the process, of which overabundant AR-V7 mRNA splicing production is currently focused and i...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tong, Dali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802141/ https://www.ncbi.nlm.nih.gov/pubmed/33430885 http://dx.doi.org/10.1186/s12935-020-01739-1

Ejemplares similares

Correction to: The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression
por: Tong, Dali
Publicado: (2021)

JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)

Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells
por: Eddy, Adrian C., et al.
Publicado: (2020)

Gene Expression Profiling Analysis of Castration-Resistant Prostate Cancer
por: Wang, Xuelei, et al.
Publicado: (2015)

Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment
por: Tong, Dali
Publicado: (2022)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

insilico Characterization and Homology Modeling of Arabitol Dehydrogenase (ArDH) from Candida albican
por: Sarwar, Muhammad Waseem, et al.
Publicado: (2013)

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021)

Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
por: Qu, Yuanyuan, et al.
Publicado: (2015)

Targeting of U2AF(65) to Sites of Active Splicing in the Nucleus
por: Gama-Carvalho, Margarida, et al.
Publicado: (1997)

The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer
por: Zheng, Zeyuan, et al.
Publicado: (2022)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways
por: Chen, Li, et al.
Publicado: (2017)

Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7
por: Chen, Haojie, et al.
Publicado: (2022)

The HIF/PHF8/AR axis promotes prostate cancer progression
por: Tong, D, et al.
Publicado: (2016)

Aurora A regulates expression of AR-V7 in models of castrate resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2017)

JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance
por: Cai, Xiang, et al.
Publicado: (2023)

Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis
por: Li, Nuo, et al.
Publicado: (2020)

Molecular screening of compounds to the predicted Protein-Protein Interaction site of Rb1-E7 with p53- E6 in HPV
por: Shaikh, Faraz, et al.
Publicado: (2012)

Prostate cancer in omics era
por: Gholami, Nasrin, et al.
Publicado: (2022)

Arabidopsis U2AF65 Regulates Flowering Time and the Growth of Pollen Tubes
por: Park, Hyo-Young, et al.
Publicado: (2019)

Novel non-AR therapeutic targets in castrate resistant prostate cancer
por: Toren, Paul J., et al.
Publicado: (2013)

Crosstalk between KIF15 and AR in castrate-resistant prostate cancers
por: Yang, Hanny, et al.
Publicado: (2022)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene
por: Liu, Xueyan, et al.
Publicado: (2022)

A defect in Δ(6 )and Δ(5 )desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians
por: Das, Undurti N
Publicado: (2010)

Two Arabidopsis Splicing Factors, U2AF65a and U2AF65b, Differentially Control Flowering Time by Modulating the Expression or Alternative Splicing of a Subset of FLC Upstream Regulators
por: Lee, Hee Tae, et al.
Publicado: (2023)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

Potential role of gastrointestinal microbiota composition in prostate cancer risk
por: Amirian, E Susan, et al.
Publicado: (2013)

Alpha Satellite DNA in Targeted Drug Therapy for Prostate Cancer
por: Feliciello, Isidoro, et al.
Publicado: (2023)

Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer
por: Luo, Jun
Publicado: (2016)

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

PLCε knockdown enhances the radiosensitivity of castration-resistant prostate cancer via the AR/PARP1/DNA-PKcs axis
por: Pu, Jun, et al.
Publicado: (2020)

PLCε knockdown enhances the radiosensitivity of castration-resistant prostate cancer via the AR/PARP1/DNA-PKcs axis
por: Pu, Jun, et al.
Publicado: (2022)

Opening Tight Junctions may be Key to Opening the Blood–Prostate Barrier
por: Shang, Yonggang, et al.
Publicado: (2014)

A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
por: Capaia, Matteo, et al.
Publicado: (2018)

Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model
por: Xu, Xiaohui, et al.
Publicado: (2015)

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer()()
por: Qiao, Yuanyuan, et al.
Publicado: (2016)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8egjij9vsdondn5qvuo3umqglj